Evolution of the incidence and aetiology of fever of unknown origin (FUO), and survival in HIV-infected patients after HAART (Highly Active Antiretroviral Therapy)

European Journal of Internal Medicine

Volumn 20, Issue 5, 2009, Pages 474-477

  Abellán Martínez, Javier ^a   Guerra Vales, Juan Manuel ^a   Fernández Cotarelo, María José ^a   González Alegre, María Teresa ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Aetiology; Fever of unknown origin; HAART; HIV; Incidence; Survival

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BLOOD CULTURE; BONE MARROW BIOPSY; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LEISHMANIASIS; LIVER BIOPSY; LUNG TUBERCULOSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOBACTERIUM INTRACELLULARE AVIUM; NEEDLE BIOPSY; PATHOPHYSIOLOGY; PYREXIA IDIOPATHICA; SURVIVAL TIME; SYSTEMIC DISEASE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FEVER OF UNKNOWN ORIGIN; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; SPAIN; SURVIVAL RATE;

EID: 68949182915     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.01.004     Document Type: Article

References (24)

1. Durack D.T., and Street A.C. In: Remington J.S., and Swartz M.N. (Eds). Fever of unknown origin-reexaminated and redefined. Curr Clin Top Infect Dis vol. 11 (1991), Boston 35-51
2. Bissuel F., Leport C., Perronne C., Longuet P., and Vildé J.L. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med 236 (1994) 529-535
3. Barba R., Gómez-Rodrigo J., Marco J., Rondón P., Eroles G., López Varas M., et al. Fever on unknown origin in patients with HIV. An Med Interna (Madrid) 18 (2001) 181-186
4. Riera M., Altés R., Homar F., Picco G., Salas A., Leyes M., et al. Fever of unknown origin in patients with HIV infection. Enferm Infecc Microbiol Clin 14 (1996) 581-585
5. Septowitz K.A., Telzak E.E., Carrow M., and Armstrong D. Fever among outpatients with advanced human immunodeficiency virus infection. Arch Intern Med 153 (1993) 1909-1912
6. Alonso M., Gómez J.L., Santolaria F., Rodríguez F., Esaardan H., Rodríguez E., et al. The efficacy of antirretroviral treatment in patients with human immunodeficiency virus infection. A study of 807 patients. Med Clin (Barc) 115 (2000) 481-486
7. Palella F.J., Delavey K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338 (1998) 860-865
8. Mayo J, Collazos J, Martínez E. Fever of unknown origin in the setting of HIV Infection: Guidelines for a Rational Approach AIDS Patients Care and STDs 1998; 12: 373-378.
9. Miralles P., Moreno S., Pérez-Tascón M., Cosín J., Díaz M.D., Bouza E., et al. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 20 (1995) 872-875
10. Kreijn E., Vanderbroucke J.P., and Van der Meer J.W. Fever of unknown origin. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. Medicine (Baltimore) 76 (1997) 392-400
11. Mathurin S.A., Lupo S., and Alonso H.O. Fever of unknown origin in patients infected with the human immunodeficiency virus. Medicina (Buenos Aires) 60 (2000) 623-630
12. Mayo J., Collazos J., and Martínez E. Fever of unknown origin in the HIV-infected patient: new scenario for an old problem. Scan J Infect Dis 29 (1997) 327-336
13. Lozano F., Torre-Cisneros J., Santos J., León E., Domínguez A., Montesdeoca M., et al. Impact of highly active antirretroviral therapy on fever of unknown origin in HIV-infected patients. Eur J Clin Microbiol Infect Dis 21 (2002) 137-139
14. Barbado F.J., and Peña J.M. Fever of unknown origin in HIV infection. New facts of an old problem. Med Clin (Barc) 105 (1995) 615-616
15. Genné D., Chave J.P., and Glauser M.P. Fever of unknown origin in a cohort of HIV-positive patients. Schweiz med Wschr 122 (1992) 1797-1802
16. Armstrong W.S., Katz P.H., and Kazanjian J.T. Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis 28 (1999) 341-345
17. Alvar J., Canavate C., Gutierrez-Solar B., Jiménez M., Laguna F., López V.R., et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10 (1997) 298-319
18. Pintado V., Martín-Rabadán P., Rivera M.L., Moreno S., and Bouza E. Visceral leishmaniasis in human immunodeficiency virus-infected and non HIV-infected patients. Medicine (Baltimore) 80 (2001) 54-73
19. Castilla J., and De la Fuente L. Trends in the number of human immunodeficiency virus infected persons and AIDS cases in Spain: 1980-1998. Med Clin (Barc) 115 (2000) 85-89
20. Brodt H.R., Kamps B.S., Gute P., Knupp B., Staszewski S., and Helm E.B. Changing incidence of AIDS defining illnesses in the era of antirretroviral therapy. AIDS 11 (1997) 1731-1738
21. Girardi E., Antonucci G., Vanacore P., Libanore M., Errante I., Matteelli A., et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 14 (2000) 1985-1991
22. Costa R. La Infección por Mycobacterium Avium-Intracellulare Asociada al SIDA en un Hospital del Area Sur de Madrid. Estudio Clínico y Epidemiológico. Tesis Doctoral. Universidad Complutense de Madrid. 2002.
23. Villanueva J.L., Alarcón A., Bernabeu-Wittel M., Cordero E., Prados D., Regordán C., et al. Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 19 (2000) 798-801
24. Fernández-Cotarelo M.J., Abellán-Martínez J., Guerra-Vales J.M., Martínez P., Rodrigo M., and Salto E. Effect of highly active antiretroviral therapy on the incidence and clinical manifestation of visceral leishmaniasis in human immunodeficiency virus infected patients. Clin Infect Dis 37 (2003) 973-977